Prevention of wound infection in pull-through percutaneous endoscopic gastrostomy

ISRCTN ISRCTN02507711
DOI https://doi.org/10.1186/ISRCTN02507711
Protocol serial number N0025168201
Sponsor Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Funders Aintree Hospitals NHS Trust (UK), NHS R&D Support Funding
Submission date
29/09/2006
Registration date
29/09/2006
Last edited
15/03/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Suhail Ahmed
Scientific

Gastroenterology
University Hospital Aintree
Longmoor Lane
Liverpool
L9 7AL
United Kingdom

Phone +44 0151 529 5089
Email zebi14@hotmail.com

Study information

Primary study designInterventional
Study designProspective randomised double-blind trial
Secondary study designRandomised controlled trial
Scientific titlePEG Study: Prevention of wound infection in pull-through percutaneous endoscopic gastrostomy (prospective randomised double-blind trial of novel technique)
Study objectivesThe primary aim of the study is to investigate the utility of a polyurethane sheath used during PEG placements in preventing PEG site wound infection.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSurgery: Gastrostomy
InterventionThroat swabs taken at pre-PEG assessment visit; consent; patients carers advised and explained to; demographics taken; examination of the oropharynx prior to PEG insertion; routine antibiotics as per protocol.
Randomisation into 2 groups, group one will undergo standard PEG, group two will undergo PEG insertion modified by use of protective sheath; patient review on the ward at 3/7 and 14 days and wound site assessed. At sign of infection swabs taken; a cohort of patients undergoing direct puncture PEG for pre-operative orophangeal cancer will be monitored; throat swabs taken and PEG wounds assessed/scored in same way as Group 1/2.
Intervention typeProcedure/Surgery
Primary outcome measure(s)

Not provided at time of registration

Key secondary outcome measure(s)

Not provided at time of registration

Completion date01/09/2007

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target sample size at registration60
Key inclusion criteriaNot provided at time of registration
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/09/2005
Date of final enrolment01/09/2007

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Gastroenterology
Liverpool
L9 7AL
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Editorial Notes

15/03/2017: No publications found in PubMed, verifying study status with principal investigator